Generic Liability Battle Shifts With FDA’s Labeling Rule Even As Some Court Issues Remain Unresolved
Executive Summary
Teva attorney says forthcoming proposed rule to allow ANDA holders to change their labels raises host of questions; generic manufacturers have lost some cases alleging failure to update their label, which may lead to another Supreme Court review.